Healionics

Focus: Healionics is a Seattle-based biotechnology company specializing in biomaterials for medical devices, with a primary focus on vascular access solutions for renal disease patients.

Neurology

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Open Jobs

About Healionics

AI assessmentNot Hiring

No open roles listed right now. Follow Healionics to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

5 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Implant of STARgraft-2 shunt in the upper arm and subsequent use for hemodialysis access

End Stage Renal Disease

N/A

Clinical Trials (1)

NCT04783779Evaluation of STARgraft-2 for Hemodialysis Access

N/A

Help build intelligence for Healionics

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Opportunity to work on implantable biomaterial devices addressing critical unmet needs in end-stage renal disease with multiple product variants in development
Early-stage company offers potential for significant equity upside and hands-on involvement in device development and clinical validation
Specialized biomaterials expertise positions you in a niche but growing medtech segment with defensible IP

Watch Out For

Pre-revenue biotech with no disclosed funding, financial runway, or employee headcount—financial stability and longevity are unverified
Zero active job openings and minimal public visibility suggest limited near-term hiring or company activity; development stage and timeline unclear

Generated by Claude from Healionics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

STARgraft AV

End Stage Renal Disease

N/A

Clinical Trials (1)

NCT03916731Evaluation of STARgraft AV for Hemodialysis Access

N/A

Implant of STARgraft-3 shunt in the upper arm and subsequent use for hemodialysis access

End Stage Renal Disease

N/A

Clinical Trials (1)

NCT05729620Evaluation of STARgraft-3 for Hemodialysis

N/A